Health care utilization, corticosteroid use higher in patients with asthma, allergic granulomatosis

A need exists for treatments for specific eosinophilic granulomatosis with polyangiitis and medications to control symptoms and improve outcomes in patients with asthma, according to findings published in the Journal of Clinical Rheumatology.

“This is the first study to use large U.S. administrative claims data from millions of commercially insured individuals to quantify the burden of disease associated with eosinophilic granulomatosis with polyangiitis (EGPA), a rare, but debilitating disease,” Mugdha Gokhale, PhD, from the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, told Healio Pulmonology.